Blue Owl Capital Holdings »

Braze shares owned by Blue Owl Capital Holdings

Quarter-by-quarter ownership of Braze (BRZE) shares owned by Blue Owl Capital Holdings from 13F filings

Historical chart of Blue Owl Capital Holdings investment in Braze

Tip: Access up to 7 years of quarterly data

All positions including Braze held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Braze by Blue Owl Capital Holdings

Quarter filed Position value Share count Share price at filing
2023-12-31 $942k 18k 53.13

More positions owned by Blue Owl Capital Holdings

Pliant Therapeutics (PLRX)
Robinhood Mkts Com Cl A (HOOD)
Cullinan Oncology (CGEM)
Tourmaline Bio (TRML)
Klaviyo Com Ser A (KVYO)
Owl Rock Capital Corporation (OBDC)
Repare Therapeutics Ord (RPTX)
Acelyrin (SLRN)
Larimar Therapeutics (LRMR)
Keros Therapeutics (KROS)
Ultragenyx Pharmaceutical (RARE)
Engene Holdings (ENGN)
Syros Pharmaceuticals Com New (SYRS)
Disc Medicine (IRON)
E2open Parent Holdings Com Cl A (ETWO)

View all positions for Blue Owl Capital Holdings

Top funds holding Braze

Vanguard Group
Battery Management Corp.
Healthcare Of Ontario Pension Plan Trust Fund
Alliancebernstein
Sapphire Ventures
Cadian Capital Management
T. Rowe Price Associates
Deutsche Bank Aktiengesellschaft
Fiera Capital Corporation
Norges Bank Investment Management
Federated Investors
Voloridge Investment Management
D. E. Shaw & Co
Bank of New York Mellon
Charles Schwab Investment Management

View all funds holding Braze